Medicine and Dentistry
Adult T-Cell Leukemia/Lymphoma
6%
B Cell
47%
B-Cell Lymphoma
23%
Burkitt's Lymphoma
7%
Cell Line
6%
Cyclophosphamide
12%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
5%
Diagnosis
10%
Diffuse Large B-Cell Lymphoma
76%
Disease
12%
DNA Microarray
11%
Doxorubicin
12%
Fluorescence in Situ Hybridization
6%
Follicle
5%
Follicular Lymphoma
20%
Formaldehyde
6%
Gene Expression
18%
Gene Expression Profiling
37%
Genomic Signature
10%
Germinal Center
27%
Germinal Center B-Cell Like Diffuse Large B-Cell Lymphoma
15%
Immunohistochemistry
7%
Large-Cell Lymphoma
7%
Leukemia Cell
5%
Lymphoma
12%
Mantle Cell Lymphoma
12%
microRNA
12%
Molecular Diagnosis
7%
Molecular Pathology
6%
Morphology
9%
Natural Killer Cell
13%
Neoplasm
28%
Next Generation Sequencing
5%
NK T Cell Lymphoma
10%
Non-Hodgkin Lymphoma
12%
Nosology
9%
Overall Survival
16%
Peripheral T-Cell Lymphoma
45%
Prednisone
12%
Prognosis
7%
Protein Expression
8%
Protein P53
5%
Rituximab
13%
Significance Analysis of Microarrays
6%
T Cell
31%
T Lymphocyte Receptor
10%
T-Cell Lymphoma
5%
Transcription Factor GATA 3
5%
Tumor Suppressor Gene
6%
Vincristine
12%
Biochemistry, Genetics and Molecular Biology
Anaplastic Lymphoma Kinase
10%
Array Comparative Genomic Hybridization
7%
B Cell
89%
Basic Fibroblast Growth Factor
5%
BCL6
5%
Caveolin 1
5%
CD28
5%
Clonal Evolution
5%
Comparative Genomic Hybridization
10%
Copy Number Analysis
5%
Cyclophosphamide
5%
Cytogenetics
14%
DNA Methyltransferase
5%
DNA Microarray
17%
Eicosanoid Receptor
13%
Epigenetics
7%
GATA3
5%
Gene Dosage
5%
Gene Expression
15%
Gene Expression Profiling
51%
Gene Mutation
18%
Genetics
34%
Messenger RNA
10%
Methylome
5%
Microarrays
7%
MicroRNA
13%
Morphology
6%
Mouse
20%
Natural Killer Cell
16%
Oncogene
5%
Overall Survival
11%
Peripheral T-Cell Lymphoma Not Otherwise Specified
7%
PRDM1
10%
Principal Component Analysis
5%
Rituximab
5%
RNA Sequencing
11%
SETD2
7%
Significance Analysis of Microarrays
6%
STAT3
8%
STAT5B
6%
T Cell
100%
T Cell Receptor
18%
TCF4
5%
TRAIL
5%
Transcription Factor EZH2
10%
Transcriptome
6%
Tumor Progression
7%
Tumor Suppressor Gene
8%
Tumor-Associated Macrophage
5%
Ubiquitin
5%
Keyphrases
Activated B Cells
5%
Activating mutation
5%
Bcl-2 Expression
5%
Bcl-2-associated X Protein
5%
CD43
5%
ChimeRScope
5%
Convergent mutation
5%
Copy number Analysis
5%
Dasatinib
5%
Diagnostic Test Accuracy
5%
Diffuse Large B-cell Lymphoma (DLBCL)
14%
DNA chip
5%
Enhancer of Zeste Homolog 2 (EZH2)
5%
Follicular Lymphoma
8%
GATA3
7%
Gene Expression Alterations
5%
Gene Expression Profiling
8%
Germinal Center B Cells
7%
HACE1
5%
Herbivore-induced
5%
Immune Cell Signature
5%
Induced Pluripotent Stem Cells (iPSCs)
5%
Kinase Fusion
5%
Lennert's Lymphoma
5%
Lymphoid Neoplasms
5%
Lymphoma
6%
Lymphomagenesis
5%
Magnetic Beads
5%
Microarray Data
5%
Molecular Genotyping
5%
Molecular Insight
5%
Molecular Profiling
5%
Molecular Subgroups
6%
Natural Killer Cells
6%
Nicotiana Attenuata
5%
Not Otherwise Specified
5%
Oncogenic Pathways
7%
Peripheral T-cell Lymphoma
30%
Peripheral T-cell lymphoma-NOS
5%
Phase II Study
5%
Plasma Cell Differentiation
5%
Prognostic Marker
5%
Sequence-specific Oligonucleotide
5%
Specialist Herbivore
5%
Sphingidae
5%
STAT5A
5%
T Cells
8%
TBX21
5%
Tumor
5%
World Health Organization Classification
5%
